Bharat Biotech cuts vaccine price for states to Rs 400 per dose

It had previously priced Covaxin COVID-19 vaccine to state governments at Rs 600 per dose

Bharat Biotech cuts vaccine price for states to Rs 400 per dose

Photo for representation.

New Delhi, April 29

Bharat Biotech on Thursday announced a cut in price of its COVID-19 vaccine ‘Covaxin’ it plans to sell to the states to Rs 400 per dose from the earlier Rs 600.

This follows a widespread criticism of its pricing policy as it sold Covaxin to the Central government at Rs 150 per dose.

Also read:

Serum Institute brings Covishield procurement price for states down to Rs 300

“Recognising the enormous challenges in the public healthcare system, we have made Covaxin available to state governments at a price of 400/dose”, Bharat Biotech said in its announcement.

The company is deeply concerned with the critical pandemic circumstances that India is facing at this time, it added.

Serum Institute of India (SII) had on Wednesday slashed the price of its COVID-19 vaccine ‘Covishield’ to Rs 300 per dose from the earlier Rs 400 for state governments. PTI

Top Stories

Bodies of suspected COVID-19 victims found floating in Ganges in Bihar

Bodies of suspected COVID-19 victims found floating in Ganges in Bihar

District administration claim corpses came with flow of rive...

Central Vista: HC to take up early hearing plea to stop work on Tuesday

Central Vista: HC to take up early hearing plea to stop work on Tuesday

Petitioners had contended that the project was not an essent...

34 teachers die due to Covid in 18 days at AMU

34 teachers die due to Covid in 18 days at AMU

ICMR to study ‘variant'

Centre to SC on vax policy: No judicial interference needed, trust wisdom of executive

Centre to SC on vax policy: No judicial interference needed, trust wisdom of executive

'Any overzealous, though well-meaning judicial intervention ...

Did China 'intentionally release' coronaviruses?

Did China 'intentionally release' coronaviruses?

Reports suggest China probed weaponising coronaviruses five ...

Cities

View All